Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.
Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have ...
New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...
Indian researchers reveal how immune cells 'betray' the body, aiding breast cancer spread and suggesting new treatment ...
News-Medical.Net on MSN
Study shows DHPS enzyme controls macrophage maturation across multiple organs
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Bloomberg School of Public Health found that an ...
Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against ...
Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results